≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Molar incisor enamel hypoplasia

Endpoint Browser PheWeb

K11_MIH

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

3 out of 7 registries used, show all original rules.

1166

4. Check minimum number of events

None

1166

5. Include endpoints

1166

6. Filter based on genotype QC (FinnGen only)

1166

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF10

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 26829 14582 12214
Only index persons 19103 10748 8355
Unadjusted period prevalence (%)
Whole population 0.38 0.42 0.34
Only index persons 0.36 0.40 0.32
Median age at first event (years)
Whole population 10.94 11.50 10.22
Only index persons 13.36 13.99 12.56

-FinnGen-

Key figures

All Female Male
Number of individuals 1166 793 373
Unadjusted period prevalence (%) 0.24 0.27 0.16
Median age at first event (years) 18.61 21.25 13.01

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
910
Matched controls
8916
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
+∞
323.0
837
*
K00.41
ICD-10 Finland
Prenatal enamel hypoplasia
+∞
136.0
128
*
127
Kela drug reimbursment
Transplant complication
26.9
86.9
122
51
K02.0
ICD-10 Finland
Caries limited to enamel
4.1
83.2
470
1844
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
17.2
80.9
132
87
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
30.2
71.6
97
35
Z94.0
ICD-10 Finland
Kidney transplant status
34.1
71.5
94
30
H02AB09
ATC
hydrocortisone; systemic
9.7
70.5
152
181
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
10.5
60.2
123
131
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
9.3
58.5
128
154
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.4
56.7
163
296
A11CC03
ATC
alfacalcidol; systemic
17.8
55.8
89
54
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
34.7
52.9
69
21
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
19.0
51.5
80
45
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
5.1
50.4
176
401
K03.66
ICD-10 Finland
Tooth plaque
3.8
48.0
243
787
137
Kela drug reimbursment
Uraemia requiring dialysis
34.2
47.5
62
19
K03.64
ICD-10 Finland
Dental calculus supragingival
2.8
47.2
466
2417
XF602
NOMESCO Finland
Bloodpressure monitoring
18.4
46.6
73
42
L04AX01
ATC
azathioprine; systemic
7.8
46.5
113
160
L04AD01
ATC
ciclosporin; systemic
13.2
46.2
83
67
ZX120
NOMESCO Finland
Intravenous
5.1
45.1
155
344
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
19.7
45.1
69
37
L04AA06
ATC
mycophenolic acid; systemic
14.3
45.0
78
58
H02AB04
ATC
methylprednisolone; systemic
5.6
44.7
140
279
Z2221
NOMESCO Finland
Medical doctor
2.9
44.5
359
1622
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
27.7
44.3
61
23
B03XA01
ATC
erythropoietin; parenteral
38.9
44.2
56
15
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
10.3
43.2
88
92
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
43.2
320
1360
EBA15
NOMESCO Finland
Extraction of large number of teeth
9.1
42.1
92
109
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
44.0
41.3
51
12
K06.18
ICD-10 Finland
Another gingival hyperplasia
25.2
41.1
58
24
B05DA
ATC
Isotonic solutions
46.0
40.0
49
11
N04.80
ICD-10 Finland
Congenital nephrotic syndrome of the Finnish type
210.0
39.8
41
*
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
6.9
39.8
104
163
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
15.1
39.1
66
46
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
52.6
38.5
46
9
5AB14
NOMESCO Finland
NA
57.9
38.3
45
8
602
Kela drug reimbursment
Children's severe malnutrition
7.1
37.8
97
148
A12AA04
ATC
calcium carbonate; oral
18.3
37.1
58
33
Z2446
NOMESCO Finland
Social worker
3.1
36.5
236
898
ZXD05
NOMESCO Finland
Urgent procedure
2.7
36.1
316
1460
KAC00
NOMESCO Finland
Nephrectomy
36.4
35.9
46
13
K03.00
ICD-10 Finland
Approximal wear
5.9
35.2
104
191
Z99.2
ICD-10 Finland
Dependence on renal dialysis
60.0
35.1
41
7
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
35.6
34.9
45
13
Z49.2
ICD-10 Finland
Other dialysis
34.8
34.0
44
13
Z3226
NOMESCO Finland
Physiotherapist
2.7
33.6
285
1281
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
33.6
340
1691
ZX199
NOMESCO Finland
Other rote
19.9
33.0
50
26
Z94.4
ICD-10 Finland
Liver transplant status
42.0
33.0
41
10
ZXE10
NOMESCO Finland
More than one and less than three hours
2.5
32.7
339
1703
ZXE20
NOMESCO Finland
More than three and less than five hours
3.5
31.9
168
545
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
10.8
31.2
61
59
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.5
31.1
163
525
205
Kela drug reimbursment
Chronic hypertension
6.1
30.6
87
152
N18.8
ICD-10 Finland
Other chronic renal failure
16.8
30.6
49
30
L04AA01
ATC
[U] ciclosporin; systemic
18.2
29.6
46
26
FM2CE
NOMESCO Finland
NA
4.1
28.8
120
317
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
20.0
28.6
43
22
TK820
NOMESCO Finland
Peritoneal dialysis
44.5
28.6
35
8
WX882
NOMESCO Finland
High dependency care
3.5
28.0
141
439
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.7
27.8
229
994
K00.50
ICD-10 Finland
Dentinal dysplasia
22.7
27.7
40
18
TPH07
NOMESCO Finland
Cathetrisation of artery
3.8
27.4
127
368
C08CA01
ATC
amlodipine; oral
4.3
27.3
107
267
V03AG01
ATC
sodium cellulose phosphate; systemic
15.4
27.2
45
30
TK800
NOMESCO Finland
Hemodialysis
14.3
27.0
46
33
SAA04
NOMESCO Finland
Special inverstigation of mouth
2.9
27.0
183
704
RD210
NOMESCO Finland
NA
4.0
26.8
116
317
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.6
26.6
226
996
SCE00
NOMESCO Finland
Fissure closure of tooth
2.6
26.6
230
1023
B05DB
ATC
Hypertonic solutions
34.5
26.4
34
10
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
4.4
26.2
99
238
BE00A
NOMESCO Finland
NA
52.3
26.1
31
6
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.8
25.6
193
788
SFA10
NOMESCO Finland
Fillning on one surface of tooth
2.1
25.6
590
4139
Z49.1
ICD-10 Finland
Extracorporeal dialysis
19.4
25.1
38
20
Z3229
NOMESCO Finland
Other healthcare associate professional
3.1
24.3
151
545
C08CA02
ATC
felodipine; oral
10.7
24.2
47
45
ZXE00
NOMESCO Finland
One hour or less
2.1
24.0
413
2534
A41.9
ICD-10 Finland
Sepsis, unspecified
6.0
24.0
68
118
R4110
NOMESCO Finland
Physiotherapy
2.3
24.0
266
1341
Z01.2
ICD-10 Finland
Dental examination
2.1
24.0
580
4094
WX110
NOMESCO Finland
Local anesthesy
2.2
23.3
700
5380
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
13.1
23.3
41
32
SAA02
NOMESCO Finland
Basic examination of mouth
2.7
23.2
815
6763
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
23.0
187
794
SDA02
NOMESCO Finland
Parodonthologic therapy
2.1
22.9
362
2134
4AA09
NOMESCO Finland
NA
36.6
22.9
29
8
XW000
NOMESCO Finland
Bone marrow biopsy
6.6
22.7
60
95
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
8.5
22.3
49
59
WW500
NOMESCO Finland
Blood transfusion
5.2
22.2
71
143
XX4AW
NOMESCO Finland
NA
6.0
22.2
63
110
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
2.2
22.1
288
1555
Z2445
NOMESCO Finland
Psychologist
2.7
21.8
167
686
F59
ICD-10 Finland
Unspecified behavioural syndromes associated with physiological disturbances and physical factors
9.4
21.7
45
49
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
3.6
21.3
100
292
XF400
NOMESCO Finland
ECG with 12 standard connections
2.4
21.0
202
936
SAA03
NOMESCO Finland
Extended examination of mouth
2.0
21.0
594
4341
ZX121
NOMESCO Finland
Central venous catheter
9.8
20.7
42
44
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
20.5
357
2162
Z94.1
ICD-10 Finland
Heart transplant status
25.7
20.3
28
11
C03CA01
ATC
furosemide; systemic
4.0
20.3
84
220
ZXA00
NOMESCO Finland
Right side
2.6
20.2
168
718
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
4.2
20.1
80
202
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
2.7
20.0
147
586
BC00A
NOMESCO Finland
NA
27.2
19.9
27
10
Z3231
NOMESCO Finland
Registered nurse
2.0
19.8
364
2243
RS220
NOMESCO Finland
NA
5.7
19.6
57
103
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.9
19.3
589
4353
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
19.2
288
1632
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.7
19.1
87
247
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.2
18.0
70
173
K02.1
ICD-10 Finland
Caries of dentine
1.9
18.0
605
4570
C03DA01
ATC
spironolactone; oral
4.8
17.7
60
129
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
2.1
17.6
254
1407
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.5
17.3
154
681
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.4
17.3
88
274
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.7
17.2
131
529
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.4
17.2
63
147
EB1WA
NOMESCO Finland
NA
18.7
17.2
26
14
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.6
17.1
132
540
R50.9
ICD-10 Finland
Fever, unspecified
2.1
16.8
223
1189
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.8
16.8
501
3592
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
2.2
16.5
185
916
V03AE01
ATC
polystyrene sulfonate; oral
23.1
16.3
23
10
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
4.5
16.3
58
132
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
6.7
15.7
40
61
201
Kela drug reimbursment
Chronic cardiac insufficiency
6.6
15.5
40
62
ZXA10
NOMESCO Finland
Bilateral
2.2
15.4
180
906
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
16.1
15.1
24
15
6BA02
NOMESCO Finland
NA
10.4
15.1
29
28
ZXA05
NOMESCO Finland
Left side
2.4
15.0
140
632
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.8
15.0
105
403
3A013
NOMESCO Finland
NA
44.9
15.0
18
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
14.8
234
1331
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
7.0
14.7
36
52
K07.24
ICD-10 Finland
Open bite
3.8
14.7
63
171
RS221
NOMESCO Finland
NA
4.3
14.7
55
132
A05AA02
ATC
ursodeoxycholic acid; oral
5.5
14.5
43
80
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.2
14.4
45
89
IGY02
NOMESCO Finland
Psychiatric monitoring contact
2.9
14.4
93
342
TK823
NOMESCO Finland
Peritoneal permeability analysis
149.3
14.4
15
*
1AB02
NOMESCO Finland
NA
13.4
14.1
24
18
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
14.4
13.9
23
16
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.5
13.9
65
190
TFJ02
NOMESCO Finland
Muscle biopsy of heart
33.9
13.4
17
5
XA800
NOMESCO Finland
Neuropsychological investigation
2.6
13.3
105
432
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
18.2
13.3
20
11
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
5.8
13.2
37
65
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.6
13.2
38
69
TAB00
NOMESCO Finland
Lumbar puncture
3.4
13.2
64
193
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
9.7
13.1
26
27
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
7.1
12.9
31
44
C09AA02
ATC
enalapril; systemic
3.4
12.8
62
186
XX4BW
NOMESCO Finland
NA
8.1
12.7
28
35
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.9
12.7
221
1294
UDC00
NOMESCO Finland
Ear microscopy
2.6
12.6
98
399
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.3
12.6
129
609
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
31.9
12.5
16
5
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
31.9
12.5
16
5
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
8.2
12.4
27
33
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
13.1
12.3
21
16
SAA01
NOMESCO Finland
Simple examination of mouth
1.8
12.2
717
6016
ZX114
NOMESCO Finland
Intramuscular
5.4
12.1
36
68
783
NOMESCO Finland
NA
37.3
12.1
15
*
C07AB02
ATC
metoprolol; systemic
3.0
12.0
69
235
K03.28
ICD-10 Finland
Other erosion of teeth
6.1
12.0
32
53
ZXE40
NOMESCO Finland
More than seven and less than nine hours
4.2
12.0
45
109
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
4.4
11.9
42
96
N18.0
ICD-10 Finland
End-stage renal disease
13.3
11.8
20
15
WW200
NOMESCO Finland
Immunization
4.9
11.8
38
79
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
11.5
362
2531
RK220
NOMESCO Finland
NA
7.5
11.3
26
35
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.6
11.2
84
337
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
4.9
11.2
36
75
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
3.2
11.1
58
185
XF622
NOMESCO Finland
Measurement of minute volume of heart
8.9
11.1
23
26
GD1LA
NOMESCO Finland
GD
24.9
11.0
15
6
ZX131
NOMESCO Finland
Intrathecal
12.6
11.0
19
15
I15.8
ICD-10 Finland
Other secondary hypertension
12.6
11.0
19
15
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.5
11.0
38
85
K03.29
ICD-10 Finland
Erosion of teeth occupational
6.4
11.0
28
44
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.4
10.9
93
398
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
2.1
10.9
130
653
B03XA02
ATC
darbepoetin alfa; parenteral
9.2
10.9
22
24
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.5
10.8
87
363
KA1AE
NOMESCO Finland
Kidney ultrasound examination
5.6
10.6
30
54
N04.0
ICD-10 Finland
Nephrotic syndrome, minor glomerular abnormality
21.3
10.6
15
7
WW409
NOMESCO Finland
Other aferesis
21.3
10.6
15
7
B01AA03
ATC
warfarin; systemic
3.8
10.4
44
119
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.9
10.4
33
68
K07.30
ICD-10 Finland
Spacing, abnormal of tooth or teeth
1.9
10.4
160
891
ZX197
NOMESCO Finland
NA
109.0
10.3
11
*
J05AB01
ATC
aciclovir; systemic
2.0
10.3
136
711
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.8
10.2
187
1103
3A077
NOMESCO Finland
NA
23.2
10.1
14
6
324
NOMESCO Finland
NA
23.2
10.1
14
6
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
10.0
438
3305
RK110
NOMESCO Finland
NA
6.9
10.0
24
35
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
14.5
9.9
16
11
JJC00
NOMESCO Finland
Allogenic transplantation of liver
39.7
9.9
12
*
RL140
NOMESCO Finland
NA
4.2
9.8
36
86
ZY010
NOMESCO Finland
Hospital outpatient
2.0
9.8
123
632
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
4.7
9.8
32
68
RS121
NOMESCO Finland
NA
4.7
9.8
32
68
Q23.4
ICD-10 Finland
Hypoplastic left heart syndrome
12.1
9.7
17
14
B07.9
ICD-10 Finland
Verruca simplex
2.9
9.7
60
213
TJW99
NOMESCO Finland
Other minor procedure in gastrointestinal endoscopy
25.8
9.7
13
5
IEP02
NOMESCO Finland
Child-centred family therapy
3.3
9.6
47
144
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
54.5
9.6
11
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.6
9.6
32
70
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
5.8
9.5
26
45
XF600
NOMESCO Finland
Bloodpressure measurement
2.1
9.5
112
560
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.5
9.5
76
316
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.2
9.4
103
498
WX402
NOMESCO Finland
General anaesthesia
1.8
9.4
182
1090
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
10.0
9.4
18
18
2AX05
NOMESCO Finland
NA
+∞
9.3
9
*
JAH00
NOMESCO Finland
Laparotomy
4.9
9.3
29
59
KAB00
NOMESCO Finland
Biopsy of kidney or pelvis of kidney
21.5
9.3
13
6
GAE10
NOMESCO Finland
Closure of previous incision of chest wall
6.2
9.3
24
39
TJF80
NOMESCO Finland
Ostomy education
6.2
9.3
24
39
FN1BB
NOMESCO Finland
Contrast angiography of heart and/or coronary arteries after bypass surgery
5.8
9.2
25
43
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.3
9.2
90
414
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
9.0
139
775
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
5.1
9.0
27
53
L04AA05
ATC
[U] tacrolimus; systemic
36.3
8.9
11
*
TK810
NOMESCO Finland
Hemofiltration
15.5
8.9
14
9
TJD20
NOMESCO Finland
Change of gastrostomy tube
5.3
8.9
26
49
U14
ICPC
Kidney symptom/complaint
9.0
8.9
18
20
WW400
NOMESCO Finland
Plasmaferesis
18.4
8.8
13
7
Z49.0
ICD-10 Finland
Preparatory care for dialysis
23.8
8.8
12
5
FQA00
NOMESCO Finland
Orthotopic transplantation of heart
23.8
8.8
12
5
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.6
8.8
351
2563
B34.9
ICD-10 Finland
Viral infection, unspecified
2.3
8.8
85
390
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
2.9
8.7
51
177
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.5
8.7
613
5092
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
4.4
8.7
30
68
K03.0
ICD-10 Finland
Excessive attrition of teeth
3.8
8.7
35
92
D82
ICPC
Teeth/gum disease
1.5
8.6
354
2596
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
13.9
8.6
14
10
ZXD20
NOMESCO Finland
Day surgery
2.0
8.5
103
523
F43.8
ICD-10 Finland
Other reactions to severe stress
3.4
8.5
39
115
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
4.8
8.4
27
57
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
5.1
8.3
25
49
R4190
NOMESCO Finland
Nutritional therapy
2.0
8.2
111
586
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.0
8.2
107
558
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
7.0
8.1
19
27
Z94.2
ICD-10 Finland
Lung transplant status
33.0
8.0
10
*
B01.9
ICD-10 Finland
Varicella without complication
3.6
7.9
34
95
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.8
7.9
50
183
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
3.0
7.9
43
144
RS210
NOMESCO Finland
NA
7.2
7.9
18
25
K00.68
ICD-10 Finland
Other disturbance in the tooth eruption
2.5
7.8
60
244
FDF05
NOMESCO Finland
Percutaneous transluminal occlusion of aorto-pulmonary collaterals
12.9
7.8
13
10
1XC02
NOMESCO Finland
NA
12.9
7.8
13
10
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.0
7.8
98
506
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.8
7.7
139
812
K00.39
ICD-10 Finland
Indefinite enamel capacities
14.9
7.6
12
8
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
14.9
7.6
12
8
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.6
7.6
53
206
UKC02
NOMESCO Finland
Cystoscopy
2.7
7.6
49
182
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.8
7.6
48
175
SFA00
NOMESCO Finland
Small filling
2.0
7.6
102
538
ZX112
NOMESCO Finland
Subcutaneous
4.1
7.6
28
69
YNB20
NOMESCO Finland
Storage of stem cells for transplant
18.2
7.5
11
6
L01BB02
ATC
mercaptopurine; oral
4.3
7.5
26
60
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
24.7
7.5
10
*
JAF10
NOMESCO Finland
Repair of umbilical hernia
4.9
7.5
23
47
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.6
7.5
193
1256
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
2.9
7.5
44
155
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
9.9
7.4
14
14
K65.0
ICD-10 Finland
Acute peritonitis
9.9
7.4
14
14
C10AA03
ATC
pravastatin; oral
5.4
7.4
21
39
G04BE03
ATC
sildenafil; oral
7.0
7.4
17
24
WX1PA
NOMESCO Finland
Total body mineral density measurement with Dual energy X-ray absorptiometry (DXA)
6.4
7.3
18
28
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.7
7.3
50
191
R63.8
ICD-10 Finland
Other symptoms and signs concerning food and fluid intake
7.6
7.3
16
21
Z940, N0480
ICD-10 Finland
NA
+∞
7.2
7
*
N0480, Z940
ICD-10 Finland
NA
+∞
7.2
7
*
7AX01
NOMESCO Finland
NA
8.3
7.2
15
18
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
9.3
7.2
14
15
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
7.2
7.1
16
22
C64.80
ICD-10 Finland
Wilms tumour
19.8
7.1
10
5
A08.1
ICD-10 Finland
Acute gastroenteropathy due to Norovirus
19.8
7.1
10
5
130
Kela drug reimbursment
Malignant tumour
3.8
7.0
28
74
FDA00
NOMESCO Finland
Aortoplasty and aorto-pulmonary shunt for HLHS
9.9
6.9
13
13
WX002
NOMESCO Finland
Sedation and analgesia
1.9
6.9
105
580
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.8
6.9
112
633
A02BC01
ATC
omeprazole; systemic
1.7
6.9
135
810
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.3
6.9
63
283
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.2
6.8
67
311
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
4.3
6.7
23
53
FXA10
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia at concurrent surgical procedure
6.6
6.7
16
24
1XX02
NOMESCO Finland
NA
10.8
6.7
12
11
ZX196
NOMESCO Finland
NA
39.4
6.7
8
*
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.5
6.7
239
1680
ZX100
NOMESCO Finland
Oral
5.6
6.7
18
32
H66.9
ICD-10 Finland
Otitis media, unspecified
1.6
6.6
197
1324
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
22.2
6.6
9
*
K03.21
ICD-10 Finland
Erosion of teeth due to: persistent vomiting
22.2
6.6
9
*
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
2.7
6.6
43
162
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
1.9
6.5
96
523
RK230
NOMESCO Finland
NA
5.1
6.5
19
37
R62.0
ICD-10 Finland
Delayed milestone
2.3
6.5
60
270
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
12.1
6.5
11
9
JAB00
NOMESCO Finland
Division and ligature of inguinal hernia sac
3.2
6.5
31
96
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
4.3
6.4
22
51
XKD00
NOMESCO Finland
Uroflowmetry
2.4
6.4
51
213
TKA05
NOMESCO Finland
Aspiration cytology of kidney
68.9
6.4
7
*
K00.88
ICD-10 Finland
Other disorders of tooth development
68.9
6.4
7
*
E42
ICD-10 Finland
Marasmic kwashiorkor
68.9
6.4
7
*
K03.2
ICD-10 Finland
Erosion of teeth
3.8
6.4
25
66
J01MA02
ATC
ciprofloxacin; systemic
1.7
6.3
138
855
RK224
NOMESCO Finland
NA
14.1
6.3
10
7
WX1BG
NOMESCO Finland
Total body MRI with high intensity magnet
7.3
6.3
14
19
TQW99
NOMESCO Finland
Other minor procedure on skin
3.2
6.3
30
93
RT150
NOMESCO Finland
NA
3.1
6.2
31
99
JJC50
NOMESCO Finland
Resection of transplanted liver
+∞
6.2
6
*
K65.9
ICD-10 Finland
Peritonitis, unspecified
+∞
6.2
6
*
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.5
6.2
289
2146
K06.10
ICD-10 Finland
Gingival fibromatosis
26.3
6.2
8
*
RS222
NOMESCO Finland
NA
3.2
6.1
30
95
H26.3
ICD-10 Finland
Drug-induced cataract
12.4
6.0
10
8
Q20.48
ICD-10 Finland
Single ventricle
12.4
6.0
10
8

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026250) Tacrolimus [Mass/volume] in Blood
106
53
21.46
137.17
48.8
37.8
ug/l
6.3
7.0
1.49
99
48
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
85
28
32.01
128.00
10.3
8.3
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
70
15
48.60
117.75
8.0
8.5
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
73
19
40.10
117.32
6.7
6.2
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
73
19
40.10
117.32
7.0
6.4
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
78
34
24.02
106.37
8.3
9.9
mg/l
2.4
2.6
0.25
62
29
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
143
185
8.50
103.17
17.7
6.1
u/ml
152.5
1986.4
0.69
23
15
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
76
41
19.36
94.67
5.5
5.0
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
147
218
7.42
94.05
16.1
5.8
iu/ml
495.4
591.8
0.11
28
20
(3010375) cycloSPORINE [Mass/volume] in Blood
87
66
13.88
90.89
38.5
32.1
ug/l
141.5
128.3
0.49
81
61
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
229
587
4.51
80.62
15.1
5.4
ng/l
67.8
54.2
1.84
223
565
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
230
635
4.18
72.99
35.3
13.0
mg/l
1.3
1.0
11.80
224
624
(40768446) Kidney Pathology biopsy report
63
53
12.26
61.57
3.0
2.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
90
136
6.94
56.07
2.3
1.6
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
144
351
4.45
53.14
3.7
1.6
u/ml
70.2
99.5
—
8
42
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
146
364
4.35
52.31
3.7
1.6
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
329
1423
2.76
48.66
29.9
7.3
mmol/l
1.3
1.3
0.26
323
1356
(3042733) HLA Ab [Presence] in Serum
48
38
12.87
48.57
3.7
3.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
195
635
3.41
47.41
5.7
4.1
e9/l
59.7
66.0
1.66
150
398
(3037121) Protein [Mass/volume] in Urine
139
385
3.88
42.92
11.6
6.5
g/l
0.3
0.3
0.42
121
261
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
161
502
3.49
41.66
3.3
1.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
242
961
2.85
41.45
6.8
2.4
%
21.8
22.6
0.54
234
882
(3004789) Transferrin [Mass/volume] in Serum or Plasma
255
1045
2.78
41.13
6.4
2.3
g/l
2.4
2.6
4.58
246
976
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
156
494
3.42
39.32
3.4
1.5
u/ml
206.1
180.9
0.45
100
231
(3027945) Reticulocytes/100 erythrocytes in Blood
234
937
2.81
39.30
10.6
5.2
%
1.4
1.4
0.35
222
886
(3036489) Thrombin time
156
500
3.38
38.55
8.6
5.2
s
22.4
22.5
0.04
145
466
(3018677) aPTT in Platelet poor plasma by Coagulation assay
261
1120
2.65
38.20
9.8
4.4
s
30.7
30.4
0.35
261
1102
(3022948) Iron [Moles/volume] in Serum or Plasma
267
1166
2.61
37.66
6.4
2.4
umol/l
13.5
14.5
1.84
261
1103
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
80
159
5.22
37.50
3.0
1.7
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
63
101
6.41
36.96
2.5
1.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
245
1068
2.58
34.41
8.8
3.1
umol/l
302.6
4182.7
3.42
238
986
(3000991) Gas panel - Venous blood
283
1322
2.45
34.28
25.3
8.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
69
131
5.42
34.00
18.0
16.0
u/ml
0.3
0.3
1.60
48
81
(4035726)
132
414
3.40
33.61
2.3
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
102
269
3.98
33.56
2.2
1.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
77
170
4.68
31.88
3.1
1.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
71
147
4.98
31.72
3.0
1.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
74
161
4.74
31.18
2.2
1.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
76
173
4.54
30.29
4.9
3.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
90
234
4.00
30.15
3.4
1.9
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
77
180
4.42
29.68
4.8
3.2
%
7.9
9.4
1.02
65
163
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
30
25
12.05
29.28
4.3
2.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
88
233
3.92
28.74
3.2
1.8
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
209
916
2.51
28.62
14.6
4.4
umol/l
6.2
6.0
0.06
182
741
(3000060) B lymphocytes [#/volume] in Blood
73
169
4.45
28.48
4.8
3.2
e6/l
208.2
384.9
3.29
51
115
(3002032) Base excess in Venous blood by calculation
290
1489
2.21
27.49
25.4
6.6
mmol/l
1.3
1.3
0.20
258
1173
(3011412) CD3 cells [#/volume] in Blood
78
196
4.11
27.35
4.8
3.1
e9/l
1.1
1.6
2.61
58
131
(21494815) CD4 cells/100 lymphocytes in Specimen
74
181
4.21
26.89
5.0
3.2
—
42.7
—
0
6
(3051651) Icteric interference index of Serum or Plasma
50
92
5.52
25.46
6.6
4.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
60
131
4.68
25.15
4.4
3.7
umol/l
21.5
25.3
2.44
60
131
(44790049)
69
170
4.17
24.83
3.0
1.9
—
—
—
0
0
(44790047)
69
170
4.17
24.83
3.0
1.9
—
—
—
0
0
(44806118)
69
171
4.14
24.63
3.0
1.9
—
—
—
0
0
(44790048)
69
171
4.14
24.63
3.0
1.9
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
52
103
5.13
24.42
6.6
4.0
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
216
1035
2.28
23.90
4.4
2.3
nmol/l
302.4
362.7
4.53
205
978
(3052851) Hemolysis interference index of Serum or Plasma
84
245
3.54
23.81
5.5
3.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
417
2574
1.92
23.19
16.9
5.8
g/l
37.4
38.0
1.54
404
2416
(3018133) Calcium [Moles/volume] in Urine
60
140
4.37
23.16
4.4
3.4
mmol/l
2.4
2.6
0.20
55
131
(3026782) Osmolality of Urine
310
1730
2.03
23.11
7.3
2.7
mosm/kgh2o
571.2
597.9
1.20
280
1479
(3005719) IgG [Mass/volume] in Serum or Plasma
193
903
2.31
22.50
7.1
2.8
g/l
8.9
9.7
1.74
185
857
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
327
1895
1.96
21.70
5.1
2.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
163
723
2.41
21.41
2.7
2.0
u/l
5.3
6.8
1.81
111
497
(3048929) Epstein Barr virus Ab [Presence] in Serum
206
1016
2.20
21.07
3.1
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
430
2746
1.85
21.05
19.5
7.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
266
1465
2.01
20.25
7.0
2.9
e6/l
0.7
0.9
0.89
189
791
(3000850) Epithelial cells [#/volume] in Urine
308
1789
1.93
20.07
8.5
2.6
e6/l
4.9
8.4
5.18
284
1547
(42870588) Differential panel, method unspecified - Blood
534
3679
1.78
20.04
19.1
7.4
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
67
189
3.63
19.95
4.8
3.0
e9/l
0.1
0.2
3.62
49
148
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
67
190
3.61
19.80
4.8
3.0
e6/l
428.1
558.9
1.32
49
147
(3001964) Herpes simplex virus Ag [Presence] in Specimen
27
34
7.94
19.58
2.6
1.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
226
1194
2.06
19.20
24.8
6.7
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
164
764
2.28
19.16
2.6
1.8
iu/l
11.1
11.3
0.04
115
550
(3044640) Blood type and Crossmatch panel - Blood
373
2358
1.81
18.36
5.6
2.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
93
337
2.85
18.33
4.9
2.3
ml/min/173m2
55.6
91.0
5.80
24
99
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
152
701
2.29
18.15
3.0
1.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
260
1476
1.93
17.90
7.4
3.0
e6/l
2.5
3.4
1.01
185
805
(3011397) Hemoglobin [Presence] in Urine by Test strip
335
2064
1.83
17.86
5.6
2.9
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
45
103
4.41
17.81
15.7
4.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
152
708
2.27
17.71
3.2
1.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
289
1705
1.88
17.67
10.7
3.3
ph
7.4
7.4
3.00
47
287
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
103
403
2.65
17.53
2.3
1.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
245
1374
1.95
17.44
24.9
6.8
mmol/l
1.1
0.9
0.31
192
965
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
246
1382
1.94
17.42
24.9
6.8
kpa
5.0
5.0
0.49
241
1328
(3009343) pH of Capillary blood
245
1381
1.94
17.15
25.1
6.8
ph
7.4
7.4
0.78
24
49
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
55
151
3.70
17.05
1.5
1.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
221
1205
1.98
17.04
24.8
6.9
kpa
10.1
9.8
1.69
215
1158
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
492
3433
1.70
16.73
7.3
2.7
nmol/l
73.5
68.1
5.61
479
3243
(3028026) IgM [Mass/volume] in Serum or Plasma
151
719
2.22
16.65
2.7
1.9
g/l
1.0
1.1
0.30
146
684
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
381
2492
1.74
16.31
7.9
3.7
u/l
30.6
30.6
0.00
375
2378
(36304419) Bacteria [Presence] in Urine
383
2509
1.74
16.30
9.9
3.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
378
2471
1.74
16.19
10.2
3.2
e6/l
0.1
0.2
1.35
309
1823
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
57
168
3.44
15.90
2.9
2.6
—
—
—
0
0
(3024932) HLA-DR beta [Type]
30
54
5.56
15.64
1.0
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
49
133
3.73
15.45
14.9
4.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
168
858
2.07
15.44
2.6
1.9
—
—
—
0
0
(3024471) HLA-A [Type]
30
55
5.46
15.34
1.0
1.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
667
5114
1.65
15.26
11.2
5.3
u/l
115.2
99.8
4.70
641
4775
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
17
16
10.55
15.21
3.1
2.6
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
441
3046
1.67
15.20
13.5
5.7
umol/l
15.0
14.0
0.28
421
2796
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
40
95
4.24
15.12
1.9
1.9
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
48
131
3.70
15.02
2.4
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
256
1522
1.83
14.99
1.9
1.7
mmol/l
1.3
1.3
0.17
250
1380
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
420
2878
1.67
14.84
11.1
3.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
66
223
3.01
14.75
2.6
1.7
titre
46.0
74.4
—
5
27
(3009508) Creatinine [Moles/volume] in Urine
313
1988
1.74
14.60
8.2
3.9
mmol/l
7.2
8.8
6.96
293
1831
(3003181) Sodium [Moles/volume] in Urine
45
120
3.78
14.56
2.4
3.6
mmol/l
79.1
83.2
0.19
37
113
(3023368) Bacteria identified in Blood by Culture
234
1379
1.83
14.01
8.4
3.7
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
47
133
3.57
13.96
3.0
2.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
493
3569
1.61
13.72
5.9
4.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
36
86
4.20
13.52
2.2
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
654
5087
1.59
13.29
19.9
7.0
e9/l
0.6
0.5
1.90
587
4324
(3006315) Basophils [#/volume] in Blood
654
5091
1.59
13.21
19.9
7.0
e9/l
0.0
0.0
4.36
588
4335
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
481
3487
1.60
13.15
34.2
8.5
mmol/l
1.2
1.2
0.57
465
3283
(3013115) Eosinophils [#/volume] in Blood
669
5257
1.58
12.81
21.9
7.5
e9/l
0.2
0.2
0.32
610
4565
(3019198) Lymphocytes [#/volume] in Blood
673
5296
1.58
12.80
19.5
7.0
e9/l
2.1
2.2
0.85
617
4630
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
505
3723
1.58
12.74
33.1
7.9
mmol/l
1.2
1.2
0.44
472
3348
(3001122) Ferritin [Mass/volume] in Serum or Plasma
633
4926
1.57
12.52
5.1
3.0
ug/l
69.7
51.5
2.16
613
4676
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
46
138
3.36
12.52
1.8
1.7
—
—
—
0
0
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
23
40
5.73
12.42
1.7
2.3
mg/l
3.1
4.3
0.46
13
33
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
23
40
5.73
12.42
1.7
2.3
mg/l
3.2
2.4
0.19
18
35
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
23
40
5.73
12.42
1.7
2.3
mg/l
3.0
0.8
1.06
17
34
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
23
40
5.73
12.42
1.7
2.3
mg/l
3.9
5.6
0.44
18
34
(1616796) Gas panel - Central venous blood
50
159
3.18
12.40
13.4
3.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
385
2678
1.61
12.32
11.3
3.3
e6/l
33.2
48.7
0.52
314
2005
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
177
993
1.88
12.28
3.2
1.9
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
627
4887
1.56
12.18
20.5
7.1
%
3.1
3.1
0.14
610
4633
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
23
41
5.59
12.11
1.7
2.3
mg/l
1.9
0.8
0.66
17
35
(3022096) Basophils/100 leukocytes in Blood
612
4750
1.55
12.08
20.7
7.2
%
0.6
0.6
1.21
597
4512
(3000494) Fungus identified in Specimen by Culture
145
769
1.97
11.89
2.6
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
29
65
4.46
11.81
1.9
1.6
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
629
4926
1.55
11.81
20.7
7.2
%
8.7
8.1
5.68
610
4682
(3018010) Neutrophils/100 leukocytes in Blood
646
5093
1.55
11.74
19.3
6.8
%
51.4
51.6
0.21
631
4858
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
20
7.94
11.61
3.3
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
445
3247
1.56
11.39
12.8
3.8
e6/l
35.3
64.3
1.03
328
2126
(3022493) Free Hemoglobin [Mass/volume] in Plasma
29
67
4.32
11.38
5.6
5.5
mg/l
4140.3
92.3
0.48
29
62
(3037467) Urinalysis macro (dipstick) panel - Urine
722
5856
1.55
11.35
8.8
3.7
—
—
—
0
0
(21494434) Karyotype in Bone marrow
27
59
4.57
11.35
1.4
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
43
132
3.28
11.30
6.0
3.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
53
185
2.89
11.22
20.9
11.9
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
17
24
7.03
11.15
1.2
1.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
651
5178
1.53
11.08
19.9
7.0
%
33.5
33.8
0.25
634
4929
(3007853) Bacteria identified in Skin by Aerobe culture
182
1066
1.80
10.94
2.7
1.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
31
78
3.97
10.90
2.0
1.4
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
42
131
3.22
10.77
2.3
1.9
ng/l
136.5
129.3
0.15
37
124
(3015377) Calcium [Moles/volume] in Serum or Plasma
301
2031
1.61
10.67
5.5
2.5
mmol/l
2.4
2.4
1.19
283
1830
(3013650) Neutrophils [#/volume] in Blood by Automated count
690
5587
1.52
10.57
23.0
8.6
e9/l
3.5
3.6
1.43
620
4735
(3014111) Lactate [Moles/volume] in Serum or Plasma
129
684
1.95
10.56
21.0
10.9
mmol/l
1.1
1.4
3.87
120
619
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
23
47
4.87
10.46
1.5
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
236
1515
1.66
10.16
6.8
2.9
mg/l
2.3
1.2
1.00
188
1030
(3026008) Bacteria identified in Urine by Culture
320
2213
1.58
10.15
3.7
2.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
139
766
1.88
10.13
10.6
4.8
ng/l
1147.9
839.5
0.43
125
601
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
49
175
2.82
9.97
2.9
2.0
nmol/l
0.1
0.1
0.04
39
134
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
11
10
10.87
9.94
4.5
3.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
715
5874
1.50
9.89
8.3
3.8
mm/h
7.7
7.5
0.34
686
5457
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
49
176
2.80
9.87
4.1
2.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
271
1817
1.60
9.75
7.6
4.2
inr
1.1
1.1
0.06
59
585
(3034274) Bile acid [Moles/volume] in Serum --fasting
84
392
2.19
9.69
6.3
3.3
umol/l
12.4
7.4
0.85
79
314
(3015736) pH of Urine
435
3262
1.49
9.32
6.1
2.8
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
18
33
5.41
9.21
10.2
5.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
25
61
4.08
9.18
1.4
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
567
4489
1.46
9.17
13.8
5.3
mmol/l
5.9
6.1
1.61
520
4071
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
620
4995
1.46
9.15
7.4
3.3
u/l
29.6
28.0
0.43
595
4800
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
33
99
3.33
9.03
2.1
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
63
269
2.37
8.96
1.9
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
63
269
2.37
8.96
1.9
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
101
522
1.98
8.90
6.9
4.1
%
0.2
0.4
0.83
38
104
(40767503) Oxygen content in Capillary blood by calculation
37
121
3.06
8.82
6.7
2.3
%
17.3
17.8
0.47
31
66
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
14
21
6.60
8.68
3.4
6.5
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
13
18
7.15
8.64
2.5
2.1
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
23
56
4.09
8.47
1.6
1.7
nmol/l
13.8
18.6
—
5
18
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
26
70
3.70
8.37
3.1
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
104
555
1.92
8.35
7.6
4.6
%
0.3
0.5
0.74
46
141
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
30
90
3.33
8.23
2.9
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
22
53
4.13
8.22
2.4
1.4
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
19
41
4.60
8.13
1.2
1.0
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
98
522
1.92
7.92
7.5
4.7
%
0.0
0.0
0.74
40
118
(3030905) Polymorphonuclear cells [#/volume] in Blood
46
180
2.57
7.90
6.1
3.8
e9/l
3.5
3.6
0.10
46
180
(3037522) Nuclear Ab [Titer] in Serum
192
1243
1.62
7.86
1.9
1.5
titre
334.1
533.0
1.34
34
210
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
41
152
2.70
7.83
5.8
4.8
u/ml
4.8
19.4
0.98
41
132
(40768804) Tissue Pathology biopsy report
322
2342
1.48
7.76
1.8
1.8
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
730
6165
1.43
7.74
4.7
2.8
mmol/l
4.4
4.5
2.29
712
5861
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
18
39
4.58
7.66
6.3
4.4
ug/l
231.0
180.6
0.48
18
39
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
18
39
4.58
7.66
3.4
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
57
250
2.30
7.66
1.4
1.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
585
4757
1.41
7.65
23.6
8.5
e9/l
0.0
0.0
0.56
491
3723
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
319
2324
1.48
7.60
3.8
2.8
mg/l
2.6
2.6
0.02
285
2053
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
75
369
2.06
7.59
1.7
1.4
ug/l
5.8
5.5
0.07
65
347
(3009261) Glucose [Presence] in Urine by Test strip
519
4142
1.41
7.51
7.0
3.0
estimate
0.0
0.0
0.00
98
796
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
691
5796
1.41
7.50
4.5
2.6
mmol/l
1.2
1.1
0.89
668
5481
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
46
185
2.50
7.48
7.6
4.0
%
50.6
52.6
0.46
46
185
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
10
12
8.23
7.41
2.8
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
23
62
3.69
7.40
1.0
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
719
6084
1.41
7.34
4.5
2.7
mmol/l
1.4
1.4
0.77
698
5749
(3021960) Folate [Moles/volume] in Serum or Plasma
179
1158
1.61
7.32
1.8
1.3
nmol/l
20.1
19.5
0.33
169
1026
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
726
6156
1.41
7.31
4.6
2.8
mmol/l
2.6
2.7
3.10
698
5787
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
65
308
2.13
7.26
1.2
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
514
4115
1.40
7.21
9.9
4.2
estimate
0.0
0.0
0.00
99
813
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
23
64
3.57
7.08
1.3
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
12
19
6.24
7.07
4.0
1.5
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
668
5605
1.39
7.01
8.5
3.6
e6/l
217.3
399.5
0.27
13
52
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
636
5295
1.39
6.99
4.7
3.3
mmol/mol
34.7
36.6
7.63
601
5003
(3035350) Ketones [Presence] in Urine by Test strip
512
4120
1.39
6.86
7.1
2.9
estimate
0.0
0.0
0.00
91
774
(3016228) CD19 cells/100 cells in Blood
12
20
5.93
6.73
4.3
2.5
%
12.2
8.2
0.41
12
20
(21494814) CD8 cells/100 lymphocytes in Specimen
12
20
5.93
6.73
4.3
2.4
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
57
266
2.16
6.64
1.7
1.6
nmol/l
0.2
0.3
0.75
48
226
(3014148) Varicella zoster virus Ab [Titer] in Serum
59
280
2.12
6.59
1.2
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
37
143
2.59
6.56
15.4
4.7
mmol/l
1.3
1.8
0.69
19
74
(3013290) Carbon dioxide [Partial pressure] in Blood
37
143
2.59
6.56
15.4
4.7
kpa
4.8
4.9
0.54
37
143
(3027315) Oxygen [Partial pressure] in Blood
37
143
2.59
6.56
15.4
4.4
kpa
10.7
9.3
4.11
37
143
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
14
28
4.95
6.53
1.7
1.1
u/l
439.9
64.0
0.73
14
23
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
13
25
5.14
6.32
2.5
2.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
39
158
2.47
6.29
1.1
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
76
403
1.91
6.26
6.2
3.1
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
18
46
3.88
6.25
1.4
1.7
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
969
8757
1.50
6.21
17.5
7.5
u/l
25.0
24.5
0.31
955
8451
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
113
681
1.69
6.09
2.9
2.3
u/l
35.6
28.8
0.58
98
556
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
42
179
2.35
6.08
1.6
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
94
539
1.77
6.04
7.9
4.7
%
0.0
0.0
0.12
45
132
(3039162) Centromere protein B Ab [Units/volume] in Serum
32
120
2.66
6.03
1.1
1.3
—
57.0
—
0
5
(3011648) Oxygen content in Venous blood
31
115
2.69
5.97
28.7
17.2
%
10.7
11.8
1.07
31
115
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
51
238
2.15
5.96
2.7
2.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
34
134
2.53
5.82
1.8
1.3
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
968
8777
1.48
5.79
23.2
8.3
umol/l
65.1
61.9
2.22
968
8772
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
20
59
3.36
5.68
3.0
1.4
pg
31.9
32.8
0.44
20
59
(3017446) Testosterone [Moles/volume] in Serum or Plasma
99
587
1.71
5.67
2.6
2.1
nmol/l
11.1
9.1
0.88
79
490
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
253
1853
1.43
5.67
3.8
2.5
u/l
60.5
57.1
0.26
242
1725
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
11
20
5.43
5.66
4.3
1.5
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
44
198
2.22
5.64
1.1
1.3
—
4.3
—
0
20
(3009871) Measles virus Ab [Titer] in Serum
14
32
4.33
5.60
1.8
2.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
19
55
3.43
5.55
2.2
2.1
%
38.4
46.1
—
8
16
(3017143) Hepatitis C virus Ab [Presence] in Serum
225
1620
1.45
5.52
1.9
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
422
3387
1.35
5.39
2.1
1.6
g/l
1.7
1.7
0.37
262
1810
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
13
29
4.43
5.36
1.8
1.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
37
159
2.32
5.29
1.1
1.3
—
1.6
—
0
12
(3006184) Hemoglobin [Mass/volume] in Capillary blood
43
198
2.17
5.23
4.7
2.2
g/l
129.6
134.4
0.76
36
159
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
46
218
2.11
5.21
1.1
1.3
—
39.7
—
0
13
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
27
101
2.66
5.15
1.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
27
101
2.66
5.15
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
27
101
2.66
5.15
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
27
101
2.66
5.15
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
27
101
2.66
5.15
1.0
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
23
79
2.89
5.12
5.7
3.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
23
79
2.89
5.12
5.7
3.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
12
26
4.56
5.11
10.8
4.8
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
27
102
2.63
5.06
1.0
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
38
169
2.24
5.03
1.3
1.3
u/ml
2.7
4.0
1.00
19
85
(40768797) Stomach Pathology biopsy report
112
709
1.61
5.00
1.5
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
84
496
1.71
4.91
1.5
1.2
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
42
197
2.13
4.90
2.0
1.5
umol/l
4.0
5.1
1.25
37
180
(3009542) Hematocrit [Volume Fraction] of Blood
1030
9525
1.51
4.89
29.5
11.3
%
38.8
39.7
5.11
918
8300
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
11
23
4.72
4.88
1.3
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
15
41
3.62
4.78
1.5
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
708
6181
1.31
4.78
3.1
2.5
mmol/l
5.3
5.4
0.61
670
5719
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
62
339
1.84
4.70
2.3
1.7
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
10
20
4.93
4.65
1.2
1.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
75
439
1.72
4.54
16.3
12.5
mmol/l
-0.6
0.2
0.91
58
338
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
7
5
13.79
4.52
4.7
1.6
mmol/l
6.1
10.4
—
7
5
(3027801) Oxygen [Partial pressure] in Arterial blood
74
436
1.71
4.38
16.4
12.6
kpa
14.9
15.4
0.27
69
419
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
74
437
1.70
4.35
16.5
12.6
kpa
5.3
5.2
0.45
69
419
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
61
341
1.79
4.33
1.5
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
339
2705
1.32
4.33
1.9
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
75
447
1.69
4.27
1.8
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
64
366
1.76
4.22
1.7
1.5
g/l
0.2
0.2
0.16
64
354
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
10
22
4.48
4.18
1.2
1.5
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
36
170
2.11
4.16
1.3
1.3
u/ml
2.7
3.8
0.26
19
73
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
37
177
2.08
4.14
1.1
1.1
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
13
36
3.57
4.08
4.0
2.2
e9/l
0.3
0.2
0.21
13
36
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
25
102
2.43
4.05
2.9
1.7
ug/l
7.3
2.0
0.62
20
87
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
138
959
1.47
4.05
5.4
2.9
ng/l
611.8
901.9
0.55
83
476
(3002256) Pathology report gross observation
105
690
1.54
4.03
1.2
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
89
563
1.59
4.02
1.5
1.4
—
—
—
0
0
(4306422)
31
140
2.20
4.01
1.1
1.2
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
64
375
1.71
3.89
1.7
1.5
g/l
1.1
1.2
1.53
64
360
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
19
69
2.73
3.88
1.1
1.2
%
77.2
88.2
—
9
33
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
992
9192
1.39
3.84
22.7
9.1
mg/l
19.0
21.5
2.00
763
6389
(3003338) MCHC [Mass/volume]
981
9078
1.37
3.79
30.5
11.8
g/l
334.6
334.3
0.46
973
8979
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
19
70
2.69
3.78
1.1
1.1
%
87.4
91.6
—
9
34
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
20
77
2.57
3.67
1.7
1.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
140
995
1.43
3.66
2.0
1.4
u/ml
427.5
311.4
0.22
131
930
(46235355) HIV 1 and 2 tests - Meaningful Use set
422
3534
1.27
3.60
2.1
2.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
13
40
3.21
3.51
1.9
1.1
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
13
40
3.21
3.51
1.8
1.7
iu/ml
—
364710.0
—
0
5
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
13
40
3.21
3.51
1.9
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
13
40
3.21
3.51
1.9
1.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
25
110
2.25
3.47
1.2
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
893
8189
1.29
3.40
30.6
9.3
mmol/l
139.5
139.5
0.53
872
7912
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
13
41
3.13
3.38
1.2
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
23
99
2.30
3.36
2.0
2.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
125
886
1.43
3.33
1.3
1.5
pmol/l
510.7
17237437.2
0.80
117
789
(3028433) Virus identified in Specimen by Culture
16
58
2.73
3.30
1.8
1.3
—
—
—
0
0
(3020891) Body temperature
32
161
1.97
3.19
12.8
5.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
13
43
2.99
3.14
17.2
5.5
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
8
15
5.26
3.14
2.9
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
50
292
1.71
3.13
1.3
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
19
78
2.41
3.09
1.1
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
891
8202
1.27
3.07
30.9
9.3
mmol/l
3.9
3.9
3.07
863
7882
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
49
287
1.70
3.04
1.3
1.1
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
13
44
2.92
3.03
2.0
3.4
mg/l
11.9
26.6
—
6
21
(4268621)
26
124
2.08
3.00
2.2
2.3
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
9
21
4.22
2.94
1.9
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
50
298
1.67
2.92
1.3
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
65
414
1.57
2.92
1.4
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
13
45
2.85
2.92
1.8
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
22
101
2.16
2.80
2.2
2.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
126
923
1.38
2.80
1.5
1.5
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
14
52
2.66
2.78
1.5
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
14
52
2.66
2.78
3.1
2.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
52
320
1.62
2.71
1.3
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1007
9459
1.32
2.68
15.5
7.6
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
23
110
2.07
2.66
1.1
1.1
%
92.8
90.4
0.15
23
104
(3052592) Norovirus Ag [Presence] in Stool
6
10
5.90
2.66
1.5
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
13
48
2.67
2.62
1.8
1.6
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
14
54
2.56
2.60
1.5
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
29
153
1.88
2.57
5.8
2.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
45
272
1.65
2.53
7.6
3.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
13
49
2.62
2.52
2.6
2.2
umol/l
16.0
16.5
0.05
13
49
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
13
49
2.62
2.52
1.2
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
13
49
2.62
2.52
1.2
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
13
49
2.62
2.52
1.2
1.8
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
9
25
3.55
2.52
1.6
1.3
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
46
280
1.64
2.52
1.3
1.2
u/ml
0.2
0.8
—
5
15
(40760512) CD34 cells/100 cells in Bone marrow
5
7
7.02
2.51
1.2
2.3
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
6
11
5.37
2.50
2.8
1.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
46
282
1.62
2.46
9.5
7.2
inr
1.3
1.2
—
6
65
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
7
16
4.31
2.43
1.4
1.2
ug/l
8.8
11.2
—
7
16
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
185
1468
1.28
2.38
3.9
2.2
u/l
327.9
303.8
0.06
177
1416
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
12
4.92
2.36
2.0
1.8
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
6
12
4.92
2.36
1.0
1.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
193
1541
1.27
2.36
1.2
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
20
96
2.06
2.32
1.3
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
938
8774
1.24
2.30
32.9
12.0
%
13.3
13.1
3.73
922
8611
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
14
58
2.38
2.27
1.8
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
14
58
2.38
2.27
1.4
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
117
878
1.34
2.26
1.4
1.3
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
9
28
3.17
2.25
1.8
2.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
249
2059
1.24
2.25
1.7
1.6
pmol/l
101.1
97.5
0.72
123
1127
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
18
3.83
2.21
1.6
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
382
3303
1.20
2.19
1.8
1.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
223
1827
1.24
2.19
4.1
3.1
ug/g
150.1
94.4
0.87
195
1431
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
9
5.46
2.18
2.4
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
126
963
1.32
2.16
4.8
3.8
mg/l
167.6
165.3
0.01
96
739
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
8
24
3.28
2.13
1.3
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
999
9431
1.27
2.13
4.2
4.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
10
36
2.74
2.12
1.2
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
13
54
2.37
2.11
2.0
3.0
u/ml
1350.5
933.7
0.42
13
54
(3029937) Albumin [Presence] in Urine by Test strip
254
2119
1.22
2.10
8.2
3.1
estimate
0.0
0.0
0.80
93
795
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
24
128
1.86
2.10
1.8
1.3
titre
281.4
270.0
—
7
24
(3000012) Reticulocyte production index
9
30
2.95
2.10
2.4
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
45
289
1.55
2.03
1.4
1.3
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
27
152
1.76
2.00
1.4
1.3
g/l
0.4
0.4
0.29
22
129
(3044889) 12 lead EKG panel
445
3925
1.18
2.00
2.8
2.2
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
6
15
3.93
2.00
1.0
1.1
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
21
109
1.90
2.00
1.0
1.0
g/l
1.5
1.4
0.77
21
103
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
862
8032
1.20
1.99
4.6
4.2
mu/l
1.9
1.9
0.44
828
7593
(4062490)
27
153
1.75
1.96
1.4
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
76
546
1.39
1.96
1.8
1.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
41
261
1.56
1.93
25.6
16.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
240
2008
1.22
1.93
10.6
4.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
21
3.28
1.92
1.3
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
21
3.28
1.92
1.3
1.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
29
170
1.69
1.89
1.1
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
35
217
1.60
1.85
2.2
1.5
g/l
0.7
0.7
0.03
29
186
(3019060) Gas panel - Arterial blood
28
165
1.68
1.80
3.3
6.8
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
117
910
1.29
1.79
1.1
1.2
—
49.8
—
0
8
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
12
4.10
1.79
1.8
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
651
5954
1.16
1.79
12.3
6.5
ml/min/173m2
103.4
105.3
1.04
462
4180
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
16
79
2.00
1.76
1.2
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
114
886
1.29
1.76
2.1
1.9
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
7
23
2.99
1.76
1.4
1.3
nmol/l
138.1
132.7
—
7
23
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
18
93
1.91
1.76
2.2
1.4
u/ml
0.6
0.7
—
8
16
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
44
292
1.50
1.74
25.5
15.2
%
0.7
0.7
0.64
44
292
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
16
81
1.95
1.66
1.8
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
16
81
1.95
1.66
1.2
1.3
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
24
139
1.71
1.65
1.5
1.7
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
19
3.11
1.62
1.7
1.2
u/l
231.2
204.5
—
6
19
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
7
25
2.75
1.61
1.0
1.2
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
5
14
3.51
1.58
2.0
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
32
2.46
1.55
1.3
1.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
418
3730
1.15
1.54
1.6
1.7
u/ml
3.7
2.9
0.24
60
780
(3023410) Appearance of Cerebral spinal fluid
32
204
1.55
1.54
10.2
3.6
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
5
15
3.28
1.49
1.0
1.3
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
10
44
2.24
1.47
1.0
1.2
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
44
304
1.43
1.46
7.8
2.8
mg/l
483.7
385.1
0.21
44
294
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
7
28
2.46
1.41
1.1
2.0
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
5
16
3.07
1.41
4.4
4.7
ug/min
34.8
15.2
—
5
10
(3010813) Leukocytes [#/volume] in Blood
1102
10611
1.33
1.40
32.6
13.5
e9/l
6.7
6.8
1.12
1077
10180
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
68
510
1.33
1.40
4.1
3.2
—
—
—
0
0
(4010399)
61
451
1.34
1.38
1.6
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
31
202
1.52
1.38
1.3
1.4
ug/g
355.5
357.1
0.01
15
106
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
9
40
2.21
1.37
11.4
3.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
475
4305
1.14
1.37
2.0
2.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
13
66
1.94
1.36
1.2
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
29
187
1.53
1.36
1.7
1.5
u/l
18.3
10.6
0.70
23
163
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
36
244
1.46
1.34
2.5
1.8
ug/l
14.2
4.8
0.96
29
210
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
340
3017
1.15
1.34
6.8
2.8
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
17
2.89
1.33
1.0
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
23
141
1.61
1.33
1.4
1.3
—
—
—
0
0
(3024731) MCV [Entitic volume]
1100
10597
1.31
1.32
32.5
13.5
fl
87.5
87.3
0.97
1087
10442
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
9
42
2.11
1.30
1.4
1.6
—
—
—
0
0
(3035941) MCH [Entitic mass]
1100
10599
1.30
1.30
32.5
13.5
pg
29.4
29.3
1.07
1087
10446
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
33
222
1.47
1.28
1.4
1.5
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
1100
10601
1.30
1.28
32.6
13.5
e12/l
4.5
4.6
7.11
1075
10163
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
34
2.31
1.27
2.9
2.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1099
10591
1.30
1.27
32.7
13.6
e9/l
264.8
268.4
1.02
1077
10175
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
13
68
1.88
1.26
3.4
2.4
nmol/l
4.1
2.9
0.30
13
63
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
5
18
2.73
1.25
2.0
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
18
2.73
1.25
1.4
1.7
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
18
2.73
1.25
1.4
1.7
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
8
35
2.25
1.25
2.9
2.3
mmol/l
106.5
105.9
—
8
35
(3021387) Prolactin [Units/volume] in Serum or Plasma
99
796
1.24
1.21
1.5
1.6
mu/l
274.8
336.7
2.62
91
717
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
208
1793
1.17
1.21
1.9
1.9
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
37
258
1.42
1.21
1.2
1.4
u/ml
6.0
4.1
0.23
22
163
(3000963) Hemoglobin [Mass/volume] in Blood
1100
10608
1.29
1.21
33.0
13.7
g/l
131.7
133.9
5.64
1088
10461
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
41
292
1.39
1.19
8.4
2.8
e6/l
4.4
15.7
0.77
35
220
(3041354) Potassium [Moles/volume] in Venous blood
8
37
2.13
1.19
2.9
2.2
mmol/l
4.5
3.9
—
8
37
(3041096) Erythrocytes [Presence] in Urine by Automated
260
2284
1.15
1.18
6.5
2.6
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
41
293
1.39
1.17
8.4
2.9
e6/l
333.0
262.8
0.09
35
228
(3038071) Oxygen [Partial pressure] in Mixed venous blood
8
39
2.02
1.12
8.9
3.7
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
5
20
2.46
1.12
6.2
3.7
mmol/l
4.5
4.5
—
5
20
(3045788) Cell count panel - Pleural fluid
5
20
2.46
1.12
1.6
1.6
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
10
50
1.97
1.11
1.1
1.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
130
1089
1.19
1.08
1.3
1.3
titre
532.0
269.8
—
5
46
(3004588) Protein electrophoresis panel - Serum or Plasma
21
134
1.55
1.06
1.2
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
32
2.15
1.06
1.3
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
32
2.15
1.06
1.3
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
32
2.15
1.06
1.3
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
240
2117
1.14
1.03
2.3
2.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
82
972
0.81
1.03
1.2
1.3
iu/ml
89.3
149.7
0.78
27
332
(3020682) Albumin/Creatinine [Ratio] in Urine
117
978
1.19
1.00
5.6
4.5
mg/mmol
156.1
10.9
0.60
88
742
(3013139) Helicobacter pylori Ag [Presence] in Stool
63
496
1.26
0.96
1.3
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
7
36
1.91
0.95
1.0
1.0
u/ml
82.1
38.1
—
7
36
(40768795) Lymph node Pathology biopsy report
9
50
1.77
0.94
1.1
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
283
2537
1.12
0.94
1.8
1.7
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
6
26
2.27
0.94
2.3
2.7
ml
641.7
577.6
—
6
18
(3016750) Collection duration of Urine
6
26
2.27
0.94
2.5
2.6
min
556.2
551.4
—
6
18
(3019225) pH of Specimen
51
394
1.28
0.92
7.0
3.8
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
15
92
1.61
0.91
1.2
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
756
7144
1.11
0.90
4.0
3.7
pmol/l
14.5
14.3
0.87
699
6532
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
28
2.11
0.90
1.0
1.2
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
34
249
1.35
0.89
1.2
1.4
u/ml
6.0
11.3
0.45
19
145
(3028707) Methadone [Presence] in Urine by Screen method
46
571
0.78
0.89
2.2
2.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
138
1186
1.16
0.87
1.3
1.2
iu/ml
19.3
16.7
0.14
37
288
(3002621) Streptococcal DNAse B [Units/volume] in Serum
13
78
1.64
0.86
1.1
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
78
1.64
0.86
1.5
1.2
—
—
—
0
0
(3000492) Spirometry study
88
730
1.20
0.85
1.6
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
64
514
1.23
0.85
1.5
1.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
15
94
1.57
0.84
1.4
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
19
126
1.49
0.84
1.3
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
111
0.53
0.83
1.3
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
24
168
1.41
0.82
1.1
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
87
1.58
0.82
1.4
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
87
724
1.19
0.82
1.5
1.5
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
64
1.69
0.81
1.2
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
64
1.69
0.81
1.2
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
64
518
1.22
0.80
1.5
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
28
203
1.36
0.79
2.0
3.3
%
27.7
21.5
—
6
57
(3043410) Blood group antigens tested for on Red Blood Cells
0
24
0.00
0.79
0.0
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
80
1.60
0.79
1.2
1.5
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
41
316
1.28
0.78
1.5
1.5
iu/ml
0.0
0.2
0.73
15
76
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
11
170
0.63
0.76
1.5
1.3
pmol/l
87.1
48.5
0.48
11
160
(3022621) pH of Urine by Test strip
59
478
1.22
0.74
2.6
2.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
78
650
1.19
0.74
1.6
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
5
24
2.05
0.73
1.4
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
5
24
2.05
0.73
1.4
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
21
147
1.41
0.73
1.7
2.1
ug/l
0.4
0.6
1.58
12
69
(3005082) Progesterone [Moles/volume] in Serum or Plasma
17
114
1.47
0.73
1.2
1.4
nmol/l
34.7
31.2
0.22
17
104
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
132
1148
1.14
0.73
1.0
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
7
38
1.81
0.73
1.1
1.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
76
633
1.19
0.72
1.3
1.6
nmol/l
1071.5
1089.7
0.06
58
496
(3034426) Prothrombin time (PT)
7
39
1.76
0.71
1.3
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
18
123
1.44
0.71
1.9
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
71
818
0.84
0.71
2.1
2.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
64
526
1.20
0.71
1.5
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
30
226
1.31
0.69
1.2
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
41
1.68
0.68
1.9
1.7
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
7
41
1.68
0.68
1.9
1.2
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
7
41
1.68
0.68
1.4
2.4
nmol/l
3.6
2.2
—
7
41
(3045414) Leukocytes [Presence] in Urine
42
332
1.25
0.67
2.3
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
18
125
1.42
0.66
1.1
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
109
1206
0.87
0.66
1.7
2.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
78
658
1.17
0.66
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
78
658
1.17
0.66
1.4
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
43
1.60
0.65
2.1
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
10
61
1.61
0.64
3.5
1.7
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
78
660
1.17
0.64
1.4
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
78
661
1.17
0.63
1.5
1.5
—
—
—
0
0
(44813793)
21
152
1.36
0.63
1.1
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
100
0.59
0.62
1.2
1.8
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
13
86
1.49
0.61
1.3
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
19
0.00
0.60
0.0
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
88
760
1.15
0.57
8.8
3.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
17
121
1.38
0.57
1.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
52
600
0.84
0.56
1.4
1.5
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
25
190
1.30
0.56
1.2
1.2
u/ml
2.6
22.7
0.95
15
153
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
8
54
1.46
0.56
1.5
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
54
1.46
0.56
1.3
1.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
8
54
1.46
0.56
1.5
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
55
630
0.85
0.55
1.7
1.7
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
73
624
1.16
0.55
2.8
3.4
pmol/l
4.9
4.9
0.10
68
575
(3015076) Soybean IgE Ab [Units/volume] in Serum
26
200
1.28
0.54
1.1
1.2
u/ml
0.8
2.3
—
6
60
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
89
1.44
0.53
1.3
1.2
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
6
38
1.55
0.53
1.5
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
9
130
0.68
0.52
2.7
2.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
112
1214
0.89
0.52
1.7
1.9
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
6
39
1.51
0.52
1.5
1.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
6
39
1.51
0.52
1.5
2.2
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
6
39
1.51
0.52
3.0
4.5
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
13
90
1.42
0.51
1.5
1.7
pmol/l
389.6
502.1
—
8
74
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
13
90
1.42
0.51
1.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
17
124
1.35
0.50
1.0
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
34
403
0.82
0.50
1.3
1.6
mg/l
4.3
3.9
0.11
21
261
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
56
634
0.86
0.50
1.4
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
211
1934
1.08
0.48
6.6
2.8
kg/l
1.0
1.0
0.25
36
318
(3028300) Cannabinoids [Presence] in Urine
113
1218
0.90
0.48
1.7
2.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
14
185
0.74
0.48
1.4
1.7
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
23
283
0.79
0.48
1.8
2.4
nmol/l
2.0
0.5
1.61
18
244
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
14
100
1.38
0.47
1.0
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
139
1253
1.10
0.46
1.8
1.6
%
1.4
1.3
0.36
127
1134
(3016879) Cocaine [Presence] in Urine
105
1132
0.90
0.45
1.7
2.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
112
1201
0.90
0.44
1.7
1.9
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
7
50
1.37
0.44
1.4
1.1
g/l
0.3
0.3
—
7
45
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
50
1.37
0.44
1.4
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
50
1.37
0.44
1.1
1.6
—
—
—
0
0
(4027681)
13
93
1.37
0.44
1.2
1.2
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
9
125
0.70
0.43
1.4
1.6
pmol/l
209.9
162.8
—
9
119
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
10
68
1.45
0.43
5.1
4.0
mg/l
10.6
11.1
—
10
59
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
38
316
1.18
0.42
1.6
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
65
565
1.14
0.42
2.1
1.9
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
40
335
1.18
0.41
1.5
1.5
—
—
—
0
0
(40763527) Lymphocytes.vacuolated [Presence] in Blood by Light microscopy
0
16
0.00
0.41
0.0
1.1
—
0.0
—
0
10
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
36
299
1.19
0.41
3.4
2.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
10
69
1.42
0.40
1.3
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
15
112
1.32
0.40
2.6
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
18
0.00
0.39
0.0
1.2
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
18
0.00
0.39
0.0
4.1
—
0.5
—
0
18
(3042631) Mycobacterium sp identified in Specimen
5
34
1.44
0.39
9.6
5.4
—
—
—
0
0
(3006598) pH of Arterial cord blood
18
139
1.27
0.39
1.0
1.0
—
—
—
0
0
(3022670) pH of Venous cord blood
5
35
1.40
0.38
1.0
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
89
956
0.91
0.38
1.3
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
268
2506
1.06
0.37
1.8
1.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
18
219
0.80
0.36
1.9
1.9
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
10
132
0.74
0.36
1.0
1.0
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
18
141
1.26
0.35
1.0
1.0
mmol/l
19.7
19.4
0.18
18
136
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
9
119
0.74
0.35
1.9
1.6
mmol/l
6.6
6.6
—
9
75
(1002224) Polysomnography panel
25
204
1.21
0.35
1.1
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
17
133
1.26
0.34
1.9
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
6
44
1.34
0.34
1.5
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
20
238
0.82
0.34
1.1
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
6
45
1.31
0.33
1.5
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
6
85
0.69
0.33
1.0
1.2
—
—
—
0
0
(4094501)
11
81
1.33
0.32
1.1
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
25
206
1.19
0.32
2.9
3.1
ug/l
2.0
5.9
0.88
16
134
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
17
134
1.25
0.32
1.8
1.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
7
52
1.32
0.31
4.4
3.3
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
7
53
1.30
0.30
1.4
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
44
484
0.89
0.30
1.5
1.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
23
266
0.84
0.30
1.9
1.9
iu/l
3.8
5.0
—
9
99
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
7
54
1.27
0.30
1.6
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
55
1.25
0.29
1.4
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
66
707
0.91
0.29
1.5
1.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
19
222
0.84
0.28
2.8
2.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
25
284
0.86
0.27
1.2
1.5
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
8
66
1.19
0.26
1.3
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
41
447
0.90
0.25
1.0
1.1
u/ml
2.4
7.3
3.13
23
235
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
16
130
1.21
0.24
1.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
13
104
1.23
0.23
1.0
1.0
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
5
39
1.26
0.22
1.4
1.3
—
66.2
—
0
5
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
7
92
0.74
0.22
1.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
230
2179
1.04
0.21
2.0
1.9
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.5
—
15.6
—
0
10
(3017704) Immunofixation for Urine
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013931) Oligosaccharides [Presence] in Urine
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
34
300
1.11
0.21
1.5
1.2
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
13
0.00
0.20
0.0
1.1
—
55.0
—
0
8
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
128
1197
1.05
0.20
3.0
2.3
u/l
6471.8
6462.7
0.00
40
422
(3007463) Buprenorphine [Presence] in Urine
0
14
0.00
0.20
0.0
4.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
9
109
0.81
0.20
1.0
1.2
u/ml
11.6
4.5
—
9
100
(3002523) Influenza virus A Ag [Presence] in Specimen
34
301
1.11
0.20
1.4
1.2
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
9
112
0.79
0.20
1.0
1.2
u/ml
1.0
12.2
—
9
103
(3017732) Neutrophils [#/volume] in Blood
62
566
1.08
0.20
2.6
1.9
e9/l
4.2
4.2
0.04
55
507
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
47
500
0.92
0.20
2.7
2.4
%
34.1
33.2
0.20
36
372
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
121
1131
1.05
0.20
1.3
1.2
u/ml
1.7
7.9
3.49
40
392
(3051387) C reactive protein [Mass/volume] in Capillary blood
14
162
0.85
0.19
3.2
3.1
mg/l
32.9
23.1
—
9
109
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
79
1.24
0.19
1.6
1.2
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
10
79
1.24
0.19
3.6
2.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
36
322
1.10
0.18
1.1
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
12
98
1.20
0.18
3.8
2.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
11
89
1.21
0.18
2.7
1.5
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
35
375
0.91
0.17
1.1
1.1
u/ml
0.3
0.5
0.25
17
150
(44816559) Phosphatidylethanol [Mass/volume] in Blood
21
231
0.89
0.16
1.3
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
95
888
1.05
0.16
1.4
1.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
83
774
1.05
0.15
2.8
1.9
mmol/l
2.4
2.4
0.16
74
646
(3013512) EKG study
124
1169
1.04
0.15
3.0
2.4
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
6
75
0.78
0.15
1.0
1.0
—
7.5
—
0
7
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
75
0.78
0.15
1.3
1.2
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
9
77
1.15
0.15
2.4
1.7
ug/l
3.8
5.8
—
9
70
(3010726) Horse dander IgE Ab [Units/volume] in Serum
65
673
0.94
0.15
1.1
1.2
u/ml
8.1
4.2
0.24
23
213
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
79
1.12
0.15
1.8
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
79
1.12
0.15
1.8
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
80
1.10
0.15
1.8
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
81
1.09
0.14
1.8
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
35
370
0.92
0.14
1.9
2.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
23
248
0.91
0.13
1.2
1.2
iu/ml
272.0
211.6
—
5
84
(4198724)
14
155
0.88
0.12
1.2
1.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
51
473
1.06
0.12
4.0
2.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
95
965
0.96
0.11
1.7
2.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
169
1698
0.97
0.11
1.3
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
72
736
0.96
0.11
1.3
1.3
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
10
113
0.87
0.11
2.7
1.6
%
12.7
12.9
—
10
113
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
10
113
0.87
0.11
1.0
1.6
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
37
341
1.07
0.10
1.3
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
5
44
1.11
0.10
1.2
1.1
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
5
46
1.07
0.09
1.0
1.4
—
5.4
—
0
9
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
47
1.04
0.09
1.4
1.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
26
238
1.07
0.09
1.8
2.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
22
200
1.08
0.08
2.3
1.7
—
—
—
0
0
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
5
59
0.83
0.08
1.0
1.1
u/ml
6.4
3.9
—
5
47
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
62
1.11
0.08
1.0
1.1
miu/ml
1515.9
1539.1
—
7
62
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
60
567
1.04
0.08
1.3
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
66
1.04
0.08
1.1
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
11
96
1.12
0.07
1.1
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
8
73
1.07
0.07
1.0
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
7
81
0.85
0.07
1.0
1.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
7
82
0.84
0.07
4.0
4.2
mmol/l
3.5
3.8
—
7
70
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
83
1.06
0.07
1.8
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
83
1.06
0.07
1.8
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
336
3263
1.01
0.06
2.4
2.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
53
536
0.97
0.06
1.2
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
40
407
0.96
0.05
1.1
1.1
u/ml
4.9
10.1
1.21
23
231
(3038177) Helicobacter pylori Ab [Presence] in Serum
16
147
1.07
0.04
1.2
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
139
1380
0.99
0.04
1.6
1.5
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
26
265
0.96
0.03
1.1
1.1
u/ml
4.3
5.5
—
10
83
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
22
206
1.05
0.03
1.1
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
90
869
1.02
0.03
2.1
2.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
19
178
1.05
0.02
1.5
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
60
598
0.98
0.02
1.3
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
33
332
0.97
0.02
1.1
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
43
415
1.02
0.01
1.1
1.1
u/ml
3.7
10.7
—
5
54
(3025130) Human papilloma virus identified in Specimen
14
143
0.96
0.00
2.0
1.7
—
—
—
0
0
(4034850)
16
153
1.03
0.00
8.5
6.0
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
70
689
1.00
0.00
1.2
1.2
u/ml
3.9
6.7
1.12
53
502
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
307
3007
1.00
0.00
2.2
2.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
59
578
1.00
0.00
1.4
1.3
miu/ml
153.7
249.9
1.20
24
289
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
38
375
0.99
0.00
1.4
1.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
77
750
1.01
0.00
1.3
1.2
u/ml
1.6
2.7
0.80
47
460
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
149
1457
1.00
0.00
2.7
2.3
ng/l
52.9
16.0
1.02
70
507
(3008898) HLA-B27 [Presence]
55
537
1.00
0.00
1.1
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
68
671
0.99
0.00
1.1
1.2
u/ml
0.7
1.3
0.95
49
449
(3020191) Ethanol [Moles/volume] in Serum or Plasma
9
91
0.97
0.00
1.0
1.3
promille
1.0
1.4
—
9
72
(3013166) Neutrophils/100 leukocytes in Synovial fluid
0
7
0.00
0.00
0.0
1.4
—
36.6
—
0
7
(40760409) HLA-A [Type] by High resolution
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017497) Pine Nut IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
0.0
—
0
7
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
5
57
0.86
0.00
1.2
1.8
mmol/l
6.8
5.5
—
5
51
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
0
6
0.00
0.00
0.0
1.7
—
468.0
—
0
6
(3047189) Immunofixation for 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
60
0.98
0.00
1.2
1.2
nmol/l
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
9
88
1.00
0.00
1.2
1.4
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
5
0.00
0.00
0.0
11.8
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3013862) HLA-DP [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
6
59
1.00
0.00
1.0
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
0.00
0.0
5.4
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint K11_MIH and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have K11_MIH.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: K11_MIH – Molar incisor enamel hypoplasia

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data